Presentation description

Personalized medicine via microbiome analysis is promising, but current methods are costly & lab-bound. Microfluidics can simplify this. We'll develop a device to extract DNA from stool, quantifying bacteria. Using fecal samples, we'll test its ability to track microbiota changes. Goal: a low-cost, accessible platform for real-time microbiome monitoring, even in resource-limited areas.